IBDEI2U4 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,45217,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45217,1,3,0)
;;=3^Lupus,Erythematosus,Systemic
;;^UTILITY(U,$J,358.3,45217,1,4,0)
;;=4^M32.10
;;^UTILITY(U,$J,358.3,45217,2)
;;=^5011753
;;^UTILITY(U,$J,358.3,45218,0)
;;=M32.19^^170^2254^24
;;^UTILITY(U,$J,358.3,45218,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45218,1,3,0)
;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
;;^UTILITY(U,$J,358.3,45218,1,4,0)
;;=4^M32.19
;;^UTILITY(U,$J,358.3,45218,2)
;;=^5011759
;;^UTILITY(U,$J,358.3,45219,0)
;;=M32.9^^170^2254^23
;;^UTILITY(U,$J,358.3,45219,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45219,1,3,0)
;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
;;^UTILITY(U,$J,358.3,45219,1,4,0)
;;=4^M32.9
;;^UTILITY(U,$J,358.3,45219,2)
;;=^5011761
;;^UTILITY(U,$J,358.3,45220,0)
;;=E88.1^^170^2254^17
;;^UTILITY(U,$J,358.3,45220,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45220,1,3,0)
;;=3^Lipodystrophy NOS
;;^UTILITY(U,$J,358.3,45220,1,4,0)
;;=4^E88.1
;;^UTILITY(U,$J,358.3,45220,2)
;;=^5003028
;;^UTILITY(U,$J,358.3,45221,0)
;;=C85.19^^170^2254^2
;;^UTILITY(U,$J,358.3,45221,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45221,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,45221,1,4,0)
;;=4^C85.19
;;^UTILITY(U,$J,358.3,45221,2)
;;=^5001710
;;^UTILITY(U,$J,358.3,45222,0)
;;=C85.13^^170^2254^5
;;^UTILITY(U,$J,358.3,45222,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45222,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Intra-Abdominal Lymph Nodes
;;^UTILITY(U,$J,358.3,45222,1,4,0)
;;=4^C85.13
;;^UTILITY(U,$J,358.3,45222,2)
;;=^5001704
;;^UTILITY(U,$J,358.3,45223,0)
;;=C85.16^^170^2254^6
;;^UTILITY(U,$J,358.3,45223,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45223,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
;;^UTILITY(U,$J,358.3,45223,1,4,0)
;;=4^C85.16
;;^UTILITY(U,$J,358.3,45223,2)
;;=^5001707
;;^UTILITY(U,$J,358.3,45224,0)
;;=C85.12^^170^2254^7
;;^UTILITY(U,$J,358.3,45224,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45224,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
;;^UTILITY(U,$J,358.3,45224,1,4,0)
;;=4^C85.12
;;^UTILITY(U,$J,358.3,45224,2)
;;=^5001703
;;^UTILITY(U,$J,358.3,45225,0)
;;=C85.14^^170^2254^1
;;^UTILITY(U,$J,358.3,45225,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45225,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
;;^UTILITY(U,$J,358.3,45225,1,4,0)
;;=4^C85.14
;;^UTILITY(U,$J,358.3,45225,2)
;;=^5001705
;;^UTILITY(U,$J,358.3,45226,0)
;;=C85.11^^170^2254^3
;;^UTILITY(U,$J,358.3,45226,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45226,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
;;^UTILITY(U,$J,358.3,45226,1,4,0)
;;=4^C85.11
;;^UTILITY(U,$J,358.3,45226,2)
;;=^5001702
;;^UTILITY(U,$J,358.3,45227,0)
;;=C85.15^^170^2254^4
;;^UTILITY(U,$J,358.3,45227,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45227,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
;;^UTILITY(U,$J,358.3,45227,1,4,0)
;;=4^C85.15
;;^UTILITY(U,$J,358.3,45227,2)
;;=^5001706
;;^UTILITY(U,$J,358.3,45228,0)
;;=C85.18^^170^2254^8
;;^UTILITY(U,$J,358.3,45228,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,45228,1,3,0)
;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
;;^UTILITY(U,$J,358.3,45228,1,4,0)
;;=4^C85.18
;;^UTILITY(U,$J,358.3,45228,2)
;;=^5001709
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2U4 3779 printed Sep 23, 2025@20:11:53 Page 2
IBDEI2U4 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,45217,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,45217,1,3,0)
+4 ;;=3^Lupus,Erythematosus,Systemic
+5 ;;^UTILITY(U,$J,358.3,45217,1,4,0)
+6 ;;=4^M32.10
+7 ;;^UTILITY(U,$J,358.3,45217,2)
+8 ;;=^5011753
+9 ;;^UTILITY(U,$J,358.3,45218,0)
+10 ;;=M32.19^^170^2254^24
+11 ;;^UTILITY(U,$J,358.3,45218,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,45218,1,3,0)
+14 ;;=3^Lupus,Erythematosus,Systemic,Skin Involvmnt
+15 ;;^UTILITY(U,$J,358.3,45218,1,4,0)
+16 ;;=4^M32.19
+17 ;;^UTILITY(U,$J,358.3,45218,2)
+18 ;;=^5011759
+19 ;;^UTILITY(U,$J,358.3,45219,0)
+20 ;;=M32.9^^170^2254^23
+21 ;;^UTILITY(U,$J,358.3,45219,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,45219,1,3,0)
+24 ;;=3^Lupus,Erythematosus,Systemic w/o Organ Involvmnt
+25 ;;^UTILITY(U,$J,358.3,45219,1,4,0)
+26 ;;=4^M32.9
+27 ;;^UTILITY(U,$J,358.3,45219,2)
+28 ;;=^5011761
+29 ;;^UTILITY(U,$J,358.3,45220,0)
+30 ;;=E88.1^^170^2254^17
+31 ;;^UTILITY(U,$J,358.3,45220,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,45220,1,3,0)
+34 ;;=3^Lipodystrophy NOS
+35 ;;^UTILITY(U,$J,358.3,45220,1,4,0)
+36 ;;=4^E88.1
+37 ;;^UTILITY(U,$J,358.3,45220,2)
+38 ;;=^5003028
+39 ;;^UTILITY(U,$J,358.3,45221,0)
+40 ;;=C85.19^^170^2254^2
+41 ;;^UTILITY(U,$J,358.3,45221,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,45221,1,3,0)
+44 ;;=3^B-Cell Lymphoma,Unspec,Extranodal/Solid Organ Sites
+45 ;;^UTILITY(U,$J,358.3,45221,1,4,0)
+46 ;;=4^C85.19
+47 ;;^UTILITY(U,$J,358.3,45221,2)
+48 ;;=^5001710
+49 ;;^UTILITY(U,$J,358.3,45222,0)
+50 ;;=C85.13^^170^2254^5
+51 ;;^UTILITY(U,$J,358.3,45222,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,45222,1,3,0)
+54 ;;=3^B-Cell Lymphoma,Unspec,Intra-Abdominal Lymph Nodes
+55 ;;^UTILITY(U,$J,358.3,45222,1,4,0)
+56 ;;=4^C85.13
+57 ;;^UTILITY(U,$J,358.3,45222,2)
+58 ;;=^5001704
+59 ;;^UTILITY(U,$J,358.3,45223,0)
+60 ;;=C85.16^^170^2254^6
+61 ;;^UTILITY(U,$J,358.3,45223,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,45223,1,3,0)
+64 ;;=3^B-Cell Lymphoma,Unspec,Intrapelvic Lymph Nodes
+65 ;;^UTILITY(U,$J,358.3,45223,1,4,0)
+66 ;;=4^C85.16
+67 ;;^UTILITY(U,$J,358.3,45223,2)
+68 ;;=^5001707
+69 ;;^UTILITY(U,$J,358.3,45224,0)
+70 ;;=C85.12^^170^2254^7
+71 ;;^UTILITY(U,$J,358.3,45224,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,45224,1,3,0)
+74 ;;=3^B-Cell Lymphoma,Unspec,Intrathoracic Lymph Nodes
+75 ;;^UTILITY(U,$J,358.3,45224,1,4,0)
+76 ;;=4^C85.12
+77 ;;^UTILITY(U,$J,358.3,45224,2)
+78 ;;=^5001703
+79 ;;^UTILITY(U,$J,358.3,45225,0)
+80 ;;=C85.14^^170^2254^1
+81 ;;^UTILITY(U,$J,358.3,45225,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,45225,1,3,0)
+84 ;;=3^B-Cell Lymphoma,Unspec,Axilla/Upper Limb Lymph Nodes
+85 ;;^UTILITY(U,$J,358.3,45225,1,4,0)
+86 ;;=4^C85.14
+87 ;;^UTILITY(U,$J,358.3,45225,2)
+88 ;;=^5001705
+89 ;;^UTILITY(U,$J,358.3,45226,0)
+90 ;;=C85.11^^170^2254^3
+91 ;;^UTILITY(U,$J,358.3,45226,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,45226,1,3,0)
+94 ;;=3^B-Cell Lymphoma,Unspec,Head/Face/Neck Lymph Nodes
+95 ;;^UTILITY(U,$J,358.3,45226,1,4,0)
+96 ;;=4^C85.11
+97 ;;^UTILITY(U,$J,358.3,45226,2)
+98 ;;=^5001702
+99 ;;^UTILITY(U,$J,358.3,45227,0)
+100 ;;=C85.15^^170^2254^4
+101 ;;^UTILITY(U,$J,358.3,45227,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,45227,1,3,0)
+104 ;;=3^B-Cell Lymphoma,Unspec,Inguinal Region/LE Lymph Nodes
+105 ;;^UTILITY(U,$J,358.3,45227,1,4,0)
+106 ;;=4^C85.15
+107 ;;^UTILITY(U,$J,358.3,45227,2)
+108 ;;=^5001706
+109 ;;^UTILITY(U,$J,358.3,45228,0)
+110 ;;=C85.18^^170^2254^8
+111 ;;^UTILITY(U,$J,358.3,45228,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,45228,1,3,0)
+114 ;;=3^B-Cell Lymphoma,Unspec,Multiple Site Lymph Nodes
+115 ;;^UTILITY(U,$J,358.3,45228,1,4,0)
+116 ;;=4^C85.18
+117 ;;^UTILITY(U,$J,358.3,45228,2)
+118 ;;=^5001709
